Literature DB >> 31076447

Spectrum of ASXL1 mutations in primary myelofibrosis: prognostic impact of the ASXL1 p.G646Wfs*12 mutation.

Giada Rotunno1,2, Carmela Mannarelli1,2, Giada Brogi1,2, Annalisa Pacilli1,2, Francesca Gesullo1,2, Francesco Mannelli1,2, Sara Fiaccabrino1,2, Benedetta Sordi1,2, Chiara Paoli1,2, Ilaria Marone1,2, Elisa Rumi3, Rossella Manfredini4, Giovanni Barosi5, Mario Cazzola3, Alessandro M Vannucchi1,2, Paola Guglielmelli1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31076447     DOI： 10.1182/blood.2018879536

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

1.  [Analysis of the effect of gene mutations on the efficacy of ruxolitinib in patients with myelofibrosis based on second-generation sequencing technology].

Authors:  Y X Tan; J Luo; J X Huang; D M Luo; H Y Liang; X Zhou; X L Liu; N Xu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2022-04-14

2.  Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study.

Authors:  Damien Luque Paz; Jérémie Riou; Emmanuelle Verger; Bruno Cassinat; Aurélie Chauveau; Jean-Christophe Ianotto; Brigitte Dupriez; Françoise Boyer; Maxime Renard; Olivier Mansier; Anne Murati; Jérôme Rey; Gabriel Etienne; Véronique Mansat-De Mas; Suzanne Tavitian; Olivier Nibourel; Stéphane Girault; Yannick Le Bris; François Girodon; Dana Ranta; Jean-Claude Chomel; Pascale Cony-Makhoul; Pierre Sujobert; Margot Robles; Raouf Ben Abdelali; Olivier Kosmider; Laurane Cottin; Lydia Roy; Ivan Sloma; Fabienne Vacheret; Mathieu Wemeau; Pascal Mossuz; Borhane Slama; Vincent Cussac; Guillaume Denis; Anouk Walter-Petrich; Barbara Burroni; Nathalie Jézéquel; Stéphane Giraudier; Eric Lippert; Gérard Socié; Jean-Jacques Kiladjian; Valérie Ugo
Journal:  Blood Adv       Date:  2021-03-09

3.  Prognostic value of ASXL1 mutations in patients with primary myelofibrosis and its relationship with clinical features: a meta-analysis.

Authors:  Ziqing Wang; Weiyi Liu; Mingjing Wang; Yujin Li; Xueying Wang; Erpeng Yang; Jing Ming; Richeng Quan; Xiaomei Hu
Journal:  Ann Hematol       Date:  2021-01-02       Impact factor: 3.673
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.